BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1857955)

  • 1. Streptococcal M protein.
    Fischetti VA
    Sci Am; 1991 Jun; 264(6):58-65. PubMed ID: 1857955
    [No Abstract]   [Full Text] [Related]  

  • 2. Changing streptococci and prospects for the global eradication of rheumatic fever.
    Stollerman GH
    Perspect Biol Med; 1997; 40(2):165-89. PubMed ID: 9058950
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection against streptococcal pharyngeal colonization with vaccines composed of M protein conserved regions.
    Fischetti VA; Bessen DE; Schneewind O; Hruby DE
    Adv Exp Med Biol; 1991; 303():159-67. PubMed ID: 1805563
    [No Abstract]   [Full Text] [Related]  

  • 4. Changing epidemiology of acute rheumatic fever in the United States.
    Lee GM; Wessels MR
    Clin Infect Dis; 2006 Feb; 42(4):448-50. PubMed ID: 16421786
    [No Abstract]   [Full Text] [Related]  

  • 5. Group A streptococcal M proteins: virulence factors and protective antigens.
    Robinson JH; Kehoe MA
    Immunol Today; 1992 Sep; 13(9):362-7. PubMed ID: 1281632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population.
    Gupta VK; Sekhar S; Dhanda V; Toor D; Kumar R; Chakraborti A
    J Microbiol Immunol Infect; 2016 Jun; 49(3):352-8. PubMed ID: 25087198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine strategies to prevent rheumatic fever.
    Brandt ER; Good MF
    Immunol Res; 1999; 19(1):89-103. PubMed ID: 10374697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity between streptococcus and human tissue: a model of molecular mimicry and autoimmunity.
    Froude J; Gibofsky A; Buskirk DR; Khanna A; Zabriskie JB
    Curr Top Microbiol Immunol; 1989; 145():5-26. PubMed ID: 2680297
    [No Abstract]   [Full Text] [Related]  

  • 9. The future streptococcal M. vaccine against rheumatic fever.
    Imran M; Jan A
    J Pak Med Assoc; 1988 Jul; 38(7):176-7. PubMed ID: 3149682
    [No Abstract]   [Full Text] [Related]  

  • 10. Intranasal immunisation of mice with a streptococcal peptide-based vaccine.
    Relf W; Hayman W; Russell-Jones G; Good M
    Adv Exp Med Biol; 1997; 418():859-61. PubMed ID: 9331788
    [No Abstract]   [Full Text] [Related]  

  • 11. The changing face of rheumatic fever in the 20th century.
    Stollerman GH
    J Med Microbiol; 1998 Aug; 47(8):655-7. PubMed ID: 9877185
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary prevention of rheumatism: the status and outlook (vaccine)].
    Rotta Y
    Ter Arkh; 1985; 57(11):97-100. PubMed ID: 3909476
    [No Abstract]   [Full Text] [Related]  

  • 13. Group A streptococcal antigens and vaccine potential.
    Kehoe MA
    Vaccine; 1991 Nov; 9(11):797-806. PubMed ID: 1722063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of group A streptococci in mice and efficacy of locally administered streptococcal vaccines.
    Bronze MS; McKinsey DS; Beachey EH; Dale JB
    Trans Assoc Am Physicians; 1988; 101():88-92. PubMed ID: 3077732
    [No Abstract]   [Full Text] [Related]  

  • 15. M proteins of Streptococcus equisimilis strains isolated from pharyngitis patients.
    Bisno AL; Collins C; Turner JC
    Adv Exp Med Biol; 1997; 418():745-8. PubMed ID: 9331759
    [No Abstract]   [Full Text] [Related]  

  • 16. Heptad motifs within the distal subdomain of the coiled-coil rod region of M protein from rheumatic fever and nephritis associated serotypes of group A streptococci are distinct from each other: nucleotide sequence of the M57 gene and relation of the deduced amino acid sequence to other M proteins.
    Manjula BN; Khandke KM; Fairwell T; Relf WA; Sriprakash KS
    J Protein Chem; 1991 Aug; 10(4):369-84. PubMed ID: 1781883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group A streptococci: pathogenesis and immunity.
    Maxted WR
    Soc Appl Bacteriol Symp Ser; 1978; 7():107-25. PubMed ID: 364656
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospects for a group A streptococcal vaccine.
    McMillan DJ; Chhatwal GS
    Curr Opin Mol Ther; 2005 Feb; 7(1):11-6. PubMed ID: 15732524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in the structural features of streptococcal M proteins from nephritogenic and rheumatogenic serotypes.
    Khandke KM; Fairwell T; Manjula BN
    J Exp Med; 1987 Jul; 166(1):151-62. PubMed ID: 3298523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated IgG titer against the C region of streptococcal M protein and its immunodeterminants in patients with poststreptococcal acute glomerulonephritis.
    Mori K; Ito Y; Kamikawaji N; Sasazuki T
    J Pediatr; 1997 Aug; 131(2):293-9. PubMed ID: 9290619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.